We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

475 hedge funds and large institutions have $9.94B invested in United Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 192 increasing their positions, 161 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $22.4M | Put options by funds: $17.2M

19% more repeat investments, than reductions

Existing positions increased: 192 | Existing positions reduced: 161

2% less capital invested

Capital invested by funds: $10.1B → $9.94B (-$195M)

2.48% less ownership

Funds ownership: 98.65% → 96.18% (-2.5%)

6% less funds holding

Funds holding: 506 → 475 (-31)

18% less funds holding in top 10

Funds holding in top 10: 17 → 14 (-3)

39% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 74

Holders
475
Holders Change
-31
Holders Change %
-6.13%
% of All Funds
7.46%
Holding in Top 10
14
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-17.65%
% of All Funds
0.22%
New
45
Increased
192
Reduced
161
Closed
74
Calls
$22.4M
Puts
$17.2M
Net Calls
+$5.14M
Net Calls Change
+$7.57M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$201M
2
O
OrbiMed
New York
+$89M
3
BlackRock
BlackRock
New York
+$76.4M
4
ITP
Iron Triangle Partners
Connecticut
+$44.3M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$30.4M

Top Sellers

1
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$107M
2
FCM
Farallon Capital Management
California
-$104M
3
PCH
Polar Capital Holdings
United Kingdom
-$72.6M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$44.4M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$39.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Aviva
476
Aviva
United Kingdom
– -$20.4M -91,015 Closed
WBC
477
Westpac Banking Corp
Australia
– -$7.49M -33,425 Closed
LOAMS
478
Lombard Odier Asset Management (Switzerland)
Switzerland
– -$5.79M -25,873 Closed
ACP
479
Acuta Capital Partners
California
– -$5.26M -23,500 Closed
PFM
480
Premier Fund Managers
United Kingdom
– -$4.6M -21,000 Closed
FEG
481
Financial Enhancement Group
Indiana
– -$3.95M -18,616 Closed
Walleye Capital
482
Walleye Capital
New York
– -$4.11M -18,574 Closed
SFI
483
Susquehanna Fundamental Investments
Pennsylvania
– -$3.36M -15,005 Closed
CAM
484
Covenant Asset Management
New Jersey
– -$3.14M -14,010 Closed
SBH
485
Segall Bryant & Hamill
Illinois
– -$3.05M -13,632 Closed
CIP
486
Chartwell Investment Partners
Pennsylvania
– -$2.87M -12,820 Closed
EF
487
Empowered Funds
Pennsylvania
– -$2.44M -10,917 Closed
TI
488
Trexquant Investment
Connecticut
– -$2.35M -10,493 Closed
EAM
489
EFG Asset Management
Oregon
– -$2.2M -9,831 Closed
EAM
490
Eagle Asset Management
Florida
– -$2.11M -9,408 Closed
ICM
491
ISZO Capital Management
New York
– -$2.02M -9,000 Closed
MWVC
492
Morgens Waterfall Vintiadis & Co
New York
– -$1.95M -8,700 Closed
Group One Trading
493
Group One Trading
Illinois
– -$1.82M -8,196 Closed
GGHC
494
Gilder Gagnon Howe & Co
New York
– -$1.6M -7,140 Closed
CSS
495
Cubist Systematic Strategies
Connecticut
– -$1.45M -6,529 Closed
Simplex Trading
496
Simplex Trading
Illinois
– -$1.41M -6,374 Closed
TA
497
Tamarack Advisers
California
– -$1.34M -6,000 Closed
SG Americas Securities
498
SG Americas Securities
New York
– -$1.32M -5,914 Closed
ESCM
499
Echo Street Capital Management
New York
– -$1.06M -4,740 Closed
DGAM
500
Desjardins Global Asset Management
Quebec, Canada
– -$1.06M -4,718 Closed
18 19
20
21 22

UTHR Hedge Fund Activity: Q2 2023 in Review

475 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2023, worth a combined $9.94B — down 1.9% from $10.1B a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of UTHR and 45 opened new positions — a net loss of 29 holders — while 161 trimmed existing stakes and 192 added.

The largest buyer was Wellington Management Group, adding an estimated $201M. The largest seller was Envestnet Asset Management, cutting an estimated $107M.

  • 475 institutional investors held United Therapeutics (UTHR) as of Q2 2023, down from 506 in Q1 2023.
  • Funds reported $9.94B of United Therapeutics stock for Q2 2023, down 1.9% quarter-over-quarter.
  • 45 funds opened new United Therapeutics positions in Q2 2023 and 74 closed out, a net change of -29 holders.
  • The largest United Therapeutics buyer in Q2 2023 was Wellington Management Group, an estimated $201M added.
  • The largest United Therapeutics seller in Q2 2023 was Envestnet Asset Management, an estimated $107M sold.

Based on aggregated 13F filings for Q2 2023.